Consistently Estimating Absolute Risk Difference when Translating Evidence to Jurisdictions of Interest (original) (raw)

The Odds Ratio is “portable” across baseline risk but not the Relative Risk: Time to do away with the log link in binomial regression

Tawanda Chivese

Journal of Clinical Epidemiology, 2021

View PDFchevron_right

What's the Relative Risk? A Method to Directly Estimate Risk Ratios in Cohort Studies of Common Outcomes

Vincent Fonseca

Annals of Epidemiology, 2002

View PDFchevron_right

Revisiting the relationship between baseline risk and risk under treatment

Jean-Pierre Boissel

Emerging Themes in Epidemiology, 2009

View PDFchevron_right

Measures of effect: relative risks, odds ratios, risk difference, and ‘number needed to treat’

Friedo Dekker

2007

View PDFchevron_right

Expression and interpretation of relative risk and odds ratio in biomedical research studies

Jitender Chaturvedi

Indian Journal of Community Health

View PDFchevron_right

Odds Ratio, Relative Risk, Absolute Risk Reduction, and the Number Needed to Treat—Which of These Should We Use?

Edna Schechtman

Value in Health, 2002

View PDFchevron_right

Baseline risk as predictor of treatment benefit: three clinical meta-re-analyses

Lidia Arends

Statistics in Medicine, 2000

View PDFchevron_right

Estimation of Relative and Absolute Risks in a Competing-Risks Setting Using a Nested Case-Control Study Design: Example From the ProMort Study

Chiara Grasso

American Journal of Epidemiology, 2019

View PDFchevron_right

Using risk difference as opposed to odds-ratio in meta-analysis

Andrea Messori

International Journal of Cardiology, 2013

View PDFchevron_right

Estimating risk and rate levels, ratios and differences in case‐control studies

Gary King

2002

View PDFchevron_right

Controversy and Debate: Questionable utility of the relative risk in clinical research: Paper 1: A call for change to practice

Tawanda Chivese

Journal of Clinical Epidemiology, 2020

View PDFchevron_right

Estimating risk difference from relative association measures in meta-analysis can infrequently pose interpretational challenges

Mohammad Murad

Journal of Clinical Epidemiology, 2009

View PDFchevron_right

Risk adjustment and outcome research. Part I

Anna Patrizia Barone

Journal of Cardiovascular Medicine, 2006

View PDFchevron_right

Analysis and design of randomised clinical trials involving competing risks endpoints

Bee Choo Tai

Trials, 2011

View PDFchevron_right

A Regression-Based Method for Estimating Risks and Relative Risks in Case-Base Studies

Wen-chung Lee

PLoS ONE, 2013

View PDFchevron_right

Potential Bias Associated with Modeling the Effectiveness of Healthcare Interventions in Reducing Mortality Using an Overall Hazard Ratio

Fernando Alarid-Escudero

PharmacoEconomics, 2019

View PDFchevron_right

A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocol

Alfonso Iorio

Systematic Reviews, 2013

View PDFchevron_right

The choice of the noninferiority margin in clinical trials was driven by baseline risk, type of primary outcome, and benefits of new treatment

Delphine Courvoisier

Journal of clinical epidemiology, 2015

View PDFchevron_right

A comparison of marginal odds ratio estimators

Christiana Drake, Travis Loux, Julie Gagen

Statistical Methods in Medical Research, 2014

View PDFchevron_right

On summary estimators of relative risk

Robert Tarone

Journal of Chronic Diseases, 1981

View PDFchevron_right

A comparison of two varying coefficient meta-analysis methods for an average risk difference

Douglas Bonett

Journal of Statistical Computation and Simulation, 2014

View PDFchevron_right

Excess Relative Risk as an Effect Measure in Case-Control Studies of Rare Diseases

Wen-chung Lee

PLOS ONE, 2015

View PDFchevron_right

Endpoint selection and relative (versus absolute) risk reporting in published medication trials

Danny McCormick

Journal of general internal medicine, 2011

View PDFchevron_right

Extrapolation of Survival Data in Cost-effectiveness Analyses: Improving the Current State of Play

Neil Hawkins

Medical Decision Making, 2013

View PDFchevron_right

Extrapolating Clinical Evidence Within Economic Evaluations

Alex Haines

Canadian Journal of Health Technologies

View PDFchevron_right

Competing event risk stratification may improve the design and efficiency of clinical trials: Secondary analysis of SWOG 8794

Sachin Gulaya

Contemporary Clinical Trials, 2013

View PDFchevron_right

Accounting for Heterogeneity in Relative Treatment Effects for Use in Cost-Effectiveness Models and Value-of-Information Analyses

Kathy Rowan

Medical decision making : an international journal of the Society for Medical Decision Making, 2015

View PDFchevron_right